These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 17351760)

  • 21. Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.
    Ibáñez C; Montoro-Ronsano JB
    Curr Pharm Biotechnol; 2003 Aug; 4(4):239-47. PubMed ID: 14529426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin and autoimmune disease.
    El-Shanawany T; Jolles S
    Ann N Y Acad Sci; 2007 Sep; 1110():507-15. PubMed ID: 17911466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):87-8. PubMed ID: 25546774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
    Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M
    Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Misra N; Latry V; Prost F; Delignat S; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Clin Biol; 2003 Jun; 10(3):165-9. PubMed ID: 12798851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.
    Kaveri SV; Dietrich G; Hurez V; Kazatchkine MD
    Clin Exp Immunol; 1991 Nov; 86(2):192-8. PubMed ID: 1934588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells.
    Maddur MS; Othy S; Hegde P; Vani J; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Clin Immunol; 2010 May; 30 Suppl 1():S4-8. PubMed ID: 20405183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.
    Blank M; Bashi T; Shoenfeld Y
    Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.
    Svetlicky N; Ortega-Hernandez OD; Mouthon L; Guillevin L; Thiesen HJ; Altman A; Kravitz MS; Blank M; Shoenfeld Y
    J Clin Immunol; 2013 Jan; 33 Suppl 1():S27-32. PubMed ID: 23229779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.
    Jordan SC; Toyoda M; Vo AA
    Expert Rev Clin Immunol; 2011 May; 7(3):341-8. PubMed ID: 21595600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.
    Wong PH; White KM
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):303-314. PubMed ID: 26142065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunoglobulins and physiopathology: actual indications].
    Mouthon L; Guilpain P
    Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravenous immunoglobulin: immunomodulatory key of the immune system].
    Ramos-Medina R; Corbí AL; Sánchez-Ramón S
    Med Clin (Barc); 2012 Jun; 139(3):112-7. PubMed ID: 22285062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of action of intravenous immunoglobulin (IVIG).
    Kazatchkine MD; Bellon B; Kaveri SV
    Mult Scler; 2000 Oct; 6 Suppl 2():S24-6; discussion S33. PubMed ID: 11188775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.